openPR Logo
Press release

Dengue Vaccines Market Generated Opportunities, Future Scope 2021-2028 | Sanofi, Takeda Pharmaceutical Company Limited, GlaxoSmithKline, and Merck & Co.

11-30-2021 12:45 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Dengue Vaccines

Dengue Vaccines

The Global Dengue Vaccines Market Is Witnessing High Growth Owing To the Increasing Incidence of Dengue in the World

Dengue Vaccines Market, By End User (Hospitals, Government Institutes, NGOs), and By Region (Latin America, Middle East, Africa, and Rest of World) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027.

Market Overview:

The most commonly reported symptom of dengue in humans is local fever with the following: nausea, vomiting, or both. However, a secondary symptom of dengue can also be present which can include medium to high fever, chills, and generalized fatigue. Aches and pains (especially behind the eyes, joint, muscle, bone, or joint pain), headache, stomachache, and dizziness may also be experienced with this form of the illness. Although these symptoms are similar to those of other forms of upper respiratory infections, they are not considered to be full-blown upper respiratory infections.

To Get more Business Statergies Request for Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/23

Competitive Landscape:

Major players operating in the global dengue vaccine market include InBios International, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Euroimmun AG (PerkinElmer), NovaTec Immundiagnostica GmbH, and Abbott Laboratories.

Key Market Drivers:

The increasing incidence of dengue in the world is expected to drive the growth of the global dengue vaccine market. For instance, according to World Mosquito Program, around 390 million individuals in the world get diagnosed with dengue infections every year. Dengue can result in a lot of uncomfortable things, such as constant watery eyes, intense pain when urinating, sudden weakness in the legs, and more. If anyone has suffered from one or more of these symptoms of dengue before, then they know that getting sick is not fun. Fortunately, there are some simple steps they can take to ensure that they stay healthy without getting sick as often. Dengue can be prevented in the same way that they prevent common colds and flu. Keeping up with a healthy diet and exercise, taking vitamin supplements, and avoiding stressful situations are all things they can do to prevent and lessen the chances of getting dengue. Increasing product launches by key market players are estimated to boost the growth of the global dengue vaccine market.

To Get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/23

Covid-19 Impact Analysis:

During the ongoing COVID-19 pandemic, the attention on other healthcare activities witnessed significant reduction, owing to increasing COVID-19 positive cases. However, key players have focused intensely on launching new products in the global market. For instance, in September 2020, DiaSys introduced an NS1 Detection kit, known as QDx Dengue NS1.

Key Takeaways:

• The size of the global dengue vaccine market is assessed to increase at a CAGR of 4.74%, owing to the increasing prevalence of dengue in the world. For instance, according to European Union, Brazil currently registered around 845720 dengue cases.

• North America is expected to hold a major share of the global dengue vaccine market, owing to the increasing incidence of dengue in the region. For instance, according to reports by World Health organizations, currently, the American region has reported around 3.1 million cases of dengue.

• The Asia Pacific is estimated to witness high growth in the global dengue vaccine market, owing to the increasing burden of dengue, along with rising awareness related to dengue programs in the region.

To Direct Purchase this Research Report – https://www.coherentmarketinsights.com/insight/buy-now/23

Table of Contents:

1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations

2. Market Overview
o Report Description
• Market Definition and Scope
o Executive Summary
• Market Snippet By Product Type
• Market Snippet By Application
• Market Snippet By Technology
• Market Snippet By End User
• Market Snippet By Region
o Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

o Market Dynamics
• Drivers
• Restraints
• Market Opportunities
o Technological Trends
o PEST Analysis
o Impact Analysis

4. Global Dengue Vaccines Market, By Product Type, 2021 – 2028 (US$ Million)

o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Reagents & Consumables
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Software’s
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Instruments
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)

5. Global Dengue Vaccines Market, By Application, 2021 – 2028 (US$ Million)

o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Genomics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Proteomics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Drug Discovery
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)

6. Global Dengue Vaccines Market, By Technology, 2021 – 2028 (US$ Million)

o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Microarrays
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Microfluidics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)

7. Global Dengue Vaccines Market, By End User, 2021 – 2028 (US$ Million)

o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Hospitals
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostic Labs
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Academic & Research Institutes
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Biotechnology & Pharmaceutical Companies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)

8. Global Dengue Vaccines Market, By Regions, 2021 – 2028 (US$ Million)

o Introduction
• Market Share Analysis, By Region, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, For Regions, 2021 – 2028
o North America
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• U.S.
• Canada
o Europe
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
o Asia Pacific
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of APAC
o Latin America
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• Brazil
• Mexico
• Rest of Latin America
o Africa
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• South Africa
• Central Africa
• North Africa
o Middle East
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• GCC
• Israel
• Rest of Middle East

Contact Us:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dengue Vaccines Market Generated Opportunities, Future Scope 2021-2028 | Sanofi, Takeda Pharmaceutical Company Limited, GlaxoSmithKline, and Merck & Co. here

News-ID: 2479722 • Views:

More Releases from Coherent Market Insights

U.K. Drug for Abuse Testing Devices Market Comprehensive Analysis of Segmental Insights, and Industry Dynamics Rapid Labs Limited.
U.K. Drug for Abuse Testing Devices Market Comprehensive Analysis of Segmental I …
Coherent Market Insights introduces new research on the U.K. Drug for Abuse Testing Devices Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights.
Cancer Cell Market Outlook 2024-2031: Experts Forecast Unprecedented Growth Opportunities, Key Players and Competitive Landscape.
Cancer Cell Market Outlook 2024-2031: Experts Forecast Unprecedented Growth Oppo …
Coherent Market Insights introduces new research on the Cancer Cell Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report also focuses
Plasma Protease C1-inhibitor Treatment Market Projected to Show Strong Growth| CSL Behring LLC, Takeda Pharmaceutical Company Limited.
Plasma Protease C1-inhibitor Treatment Market Projected to Show Strong Growth| C …
Coherent Market Insights introduces new research on the Plasma Protease C1-inhibitor Treatment Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report
Neurological Disorder Diagnostics Market 2024 | Opportunity Assessment, Strategy Insights Analysis, Segmentation And Forecast To 2031.
Neurological Disorder Diagnostics Market 2024 | Opportunity Assessment, Strategy …
Coherent Market Insights introduces new research on the Neurological Disorder Diagnostics Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report also

All 5 Releases


More Releases for Introduction

Introduction to new services
We are happy to announce that as a top digital marketing agency in Pakistan, we are also going to introduce some other services as well. These services are quite affordable for all small businesses and entrepreneurs. My Online Campaign 255 Karachi, Pakistan We are digital transformation experts who innovate and deliver. We help you bring innovative products and services to the world. Our digital services help organizations address complex business challenges and changing user expectations.
Frenchie Africa Introduction
Johannessburg, Gauteng, South Africa, 17 February 2021 – Frenchie Africa has announced the initiation of their website and Social Media channels to the public. Frenchie Africa will follow the journey of two French Bulldogs, Bakari and Jamani as they grow up in Africa. From their homebase, a small but cozy, custom-built log cabin in South Africa, Frenchie Africa will chronicle the lives of Bakari and Jamani and their owners Ross and
Versionone at a glance: introduction
One of the best known tools for agile project management is VERSION ONE. This tool in the Enterprise edition is the first one that we review in our agile tools review series. Version One as Enterprise edition is a very mature and powerful tool for managing agile teams. Pros: 1. Free entry edition: It’s a free for one team (Team Edition, SaaS). 2. Maintenance of backlogs: Easy to create and maintain product and sprint backlogs. 3. Drag&Drop features:
Introduction to MOST Basics
The MOST Cooperation, the organization through which the leading automotive multimedia network Media Oriented Systems Transport (MOST) is standardized, is starting a training program on MOST basics for its member companies. It has prepared a complimentary one-day seminar syllabus to provide an introduction to MOST Technology. "With this technical course, the MOST Cooperation is seeking to provide information on MOST to all engineers and developers who are new to working
Introduction of me-domains
The me-domain is an Internet country code top-level domain (ccTLD) that has been assigned to Montenegro. This follows Montenegro\'s June 3, 2006 declaration of independence from Serbia and Montenegro, which used the code YU. The .me registry is operated by the University of Montenegro on behalf of the government. A two-year transition period is to be provided for existing .yu names to be transferred to .me. In addition to declaring .me to
Introduction of T2 in Hannover
13th of September 2007: Torsten Zimmermann spoke at the CBG user convention, Hannover, and explained some of the latest T2 inventions. In accordance to the convention’s motto "test automation", he presented the automated T2 test run. He explained the bus concept and how the T2 platform supports all test phases: form the first planning steps up to the test completion. The new fineplanning and environment management modules fill two control and